Company / Operating Income
Lipocine Inc. Operating Income History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.2M
FY2025
5-year range
-$18.0M / $3.1M
FY2021-FY2025
Trend
+93.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$1M.
Based on SEC 10-K filings.
-$1M in FY2025.
Improved from -$12M to -$1M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 93.6% year-over-year.
- Peak operating income was recorded in FY2013.
- Lowest operating income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.2M | +93.6% |
| FY2024 | -$17.9M | -48.0% |
| FY2023 | -$12.1M | -485.3% |
| FY2022 | $3.1M | +117.5% |
| FY2021 | -$18.0M | -39.5% |
| FY2020 | -$12.9M | -13.9% |
| FY2019 | -$11.3M | +41.0% |
| FY2018 | -$19.2M | -594.9% |
| FY2013 | $3.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026